Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17420316rdf:typepubmed:Citationlld:pubmed
pubmed-article:17420316lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:17420316lifeskim:mentionsumls-concept:C0007776lld:lifeskim
pubmed-article:17420316lifeskim:mentionsumls-concept:C0022655lld:lifeskim
pubmed-article:17420316lifeskim:mentionsumls-concept:C0001613lld:lifeskim
pubmed-article:17420316lifeskim:mentionsumls-concept:C0270611lld:lifeskim
pubmed-article:17420316lifeskim:mentionsumls-concept:C1749467lld:lifeskim
pubmed-article:17420316lifeskim:mentionsumls-concept:C0332461lld:lifeskim
pubmed-article:17420316lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:17420316lifeskim:mentionsumls-concept:C0205082lld:lifeskim
pubmed-article:17420316lifeskim:mentionsumls-concept:C0205219lld:lifeskim
pubmed-article:17420316lifeskim:mentionsumls-concept:C0205217lld:lifeskim
pubmed-article:17420316lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:17420316pubmed:issue4lld:pubmed
pubmed-article:17420316pubmed:dateCreated2007-4-10lld:pubmed
pubmed-article:17420316pubmed:abstractTextTraumatic brain injury (TBI) is an environmental risk factor for developing Alzheimer disease. This may be due, in part, to changes associated with beta-amyloid (Abeta) plaque formation, which can occur within hours after injury, regardless of the patient's age. In addition to being precursors of toxic fibrils that deposit into plaques, soluble (nonfibrillar) Abeta peptides are posited to disrupt synaptic function and are associated with cognitive decline in Alzheimer disease. Changes in soluble Abeta levels and their relationship to Abeta plaque formation following TBI are unknown.lld:pubmed
pubmed-article:17420316pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17420316pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17420316pubmed:languageenglld:pubmed
pubmed-article:17420316pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17420316pubmed:citationSubsetAIMlld:pubmed
pubmed-article:17420316pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17420316pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17420316pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17420316pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17420316pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17420316pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17420316pubmed:statusMEDLINElld:pubmed
pubmed-article:17420316pubmed:monthAprlld:pubmed
pubmed-article:17420316pubmed:issn0003-9942lld:pubmed
pubmed-article:17420316pubmed:authorpubmed-author:DeKoskySteven...lld:pubmed
pubmed-article:17420316pubmed:authorpubmed-author:ClarkRobert...lld:pubmed
pubmed-article:17420316pubmed:authorpubmed-author:WisniewskiSte...lld:pubmed
pubmed-article:17420316pubmed:authorpubmed-author:IkonomovicMil...lld:pubmed
pubmed-article:17420316pubmed:authorpubmed-author:CiallellaJohn...lld:pubmed
pubmed-article:17420316pubmed:authorpubmed-author:PaljugWilliam...lld:pubmed
pubmed-article:17420316pubmed:authorpubmed-author:AbrahamsonEri...lld:pubmed
pubmed-article:17420316pubmed:issnTypePrintlld:pubmed
pubmed-article:17420316pubmed:volume64lld:pubmed
pubmed-article:17420316pubmed:ownerNLMlld:pubmed
pubmed-article:17420316pubmed:authorsCompleteYlld:pubmed
pubmed-article:17420316pubmed:pagination541-4lld:pubmed
pubmed-article:17420316pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:17420316pubmed:meshHeadingpubmed-meshheading:17420316...lld:pubmed
pubmed-article:17420316pubmed:meshHeadingpubmed-meshheading:17420316...lld:pubmed
pubmed-article:17420316pubmed:meshHeadingpubmed-meshheading:17420316...lld:pubmed
pubmed-article:17420316pubmed:meshHeadingpubmed-meshheading:17420316...lld:pubmed
pubmed-article:17420316pubmed:meshHeadingpubmed-meshheading:17420316...lld:pubmed
pubmed-article:17420316pubmed:meshHeadingpubmed-meshheading:17420316...lld:pubmed
pubmed-article:17420316pubmed:meshHeadingpubmed-meshheading:17420316...lld:pubmed
pubmed-article:17420316pubmed:meshHeadingpubmed-meshheading:17420316...lld:pubmed
pubmed-article:17420316pubmed:meshHeadingpubmed-meshheading:17420316...lld:pubmed
pubmed-article:17420316pubmed:meshHeadingpubmed-meshheading:17420316...lld:pubmed
pubmed-article:17420316pubmed:meshHeadingpubmed-meshheading:17420316...lld:pubmed
pubmed-article:17420316pubmed:meshHeadingpubmed-meshheading:17420316...lld:pubmed
pubmed-article:17420316pubmed:meshHeadingpubmed-meshheading:17420316...lld:pubmed
pubmed-article:17420316pubmed:meshHeadingpubmed-meshheading:17420316...lld:pubmed
pubmed-article:17420316pubmed:year2007lld:pubmed
pubmed-article:17420316pubmed:articleTitleAssociation of increased cortical soluble abeta42 levels with diffuse plaques after severe brain injury in humans.lld:pubmed
pubmed-article:17420316pubmed:affiliationDepartment of Neurology, University of Pittsburgh, 3471 Fifth Ave, Suite 811, Pittsburgh, PA 15213, USA. dekoskyst@upmc.edulld:pubmed
pubmed-article:17420316pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17420316pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17420316lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17420316lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17420316lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17420316lld:pubmed